OR WAIT null SECS
This compilation allows readers to adjust their thinking to appreciate the full impact certain select technologies will make on the industry by 2026.
The testing of new convecdiff membranes shows this material to be well suited for lab- and commercial-scale bind-and-elute applications.
Cautiously setting aside pandemic practices, pharma workers appear ready for flux, change, evolution, and expanding molecular diversity.
Biologic drug development requires relevant bioassays to measure and help predict cellular response.
Affinity chromatography resins must perform well under mild elution conditions yet withstand robust cleaning and sanitization protocols.
Efforts to optimize the ideal blend of technology and best practices that are needed to protect and deliver time- and temperature-sensitive biologic therapies, vaccines, and cell and gene therapies continue to evolve.
Health crises, political tension, and budget concerns were major challenges.
January 18, 2023
Vetter significantly increases its sustainability ranking by achieving gold status in EcoVadis ranking.
Pfizer and Gero have partnered to discover potential therapeutic targets for fibrotic diseases using machine learning technology.
The collaboration between AbbVie and Anima Biotech will combine Anima's mRNA Lightning technology platform with AbbVie's extensive expertise in oncology and immunology.
January 16, 2023
The guidance provides examples of required and recommended information in the Dosage and Administration section.
The agreement will be able to let FDA and the Swiss Agency for Therapeutic Products (Swissmedic) utilize each other’s GMP inspections of manufacturing facilities, avoiding the need for duplicate inspections.
The members reviewed the measures to minimize the risk of serious side effects associated with Janus kinase (JAK) inhibitors used to treat several chronic inflammatory disorders.
January 13, 2023
The Vault Quality Suite will help Adare simplify its quality operations across its sites in the United States, France, and Italy.
It is intended to identify the most prevalent and immunogenic targets in solid tumors by uniquely combining high-diversity target libraries with active machine learning.
January 11, 2023
This self-emulsifying system improves the miscibility and dispersibility of formulations in aqueous environments and may improve API solubility.
Epinephrine is a critical medication used during life-threatening conditions that can affect any age and any person.
A REMS document is a part of a REMS required by FDA and establishes the goals and requirements of the REMS.
The definitive agreement will give AstraZeneca global rights to CinCor’s portfolio of cardiorenal disease treatments.